Highlights of our experience include: 

  • Advised a multinational Fortune 500 provider of product development and integrated healthcare services in its merger with a NYSE-listed global information and technology services company, creating a leading information and tech-enabled healthcare service provider. The equity market capitalization of the joined companies was more than $17.6 billion at closing.
  • Represented privately held distributor and supplier of original automotive equipment and aftermarket replacement products in its merger with a publicly traded leading provider of automotive aftermarket parts and accessories in a transaction valued at $2.04 billion, making it one of the largest transactions in North Carolina history.
  • Represented the special committee of a publicly traded bank holding company in connection with its $645 million acquisition of another bank holding company.  The transaction was the largest bank holding company merger in the Southeast, and the third largest nationally, in 2014.
  • Advised a publicly traded supplier of water and water dispensers in an agreement to acquire by merger a publicly traded competitor for $263 million in cash and stock.
  • Advised the world’s largest provider of biopharmaceutical development and commercial outsourcing services in its acquisition of a health-information analytics and technology services company focused on healthcare providers.
  • Represented a venture capital funded agricultural biotechnology company in its $400 million acquisition by a European based ag-chemical company.
  • Represented a global solid state LED lighting and semiconductor manufacturing company in its $525 million acquisition of an outdoor LED lighting company.
  • Represented a publicly traded company and leading provider of end-to-end spend management solutions in its sale of the company to a leading technology-focused private equity firm for approximately $509 million.
  • Represented a national multimedia advertising company in its $350 million acquisition of an online advertising company.
  • Represented a public specialty pharmaceutical company in its $150 million acquisition of a private specialty pharmaceutical company.